<?xml version="1.0" encoding="UTF-8"?>
<p>Ex vivo analysis of cholinesterase (AChE and BChE) inhibitory potentials was measured using Fa.EtAc extract to assess the impairment in cholinergic functions in mice model. Percent AChE activity of frontal cortex and hippocampus tissues of different animal groups in Y-Maze test are given in 
 <xref ref-type="fig" rid="brainsci-11-00259-f006">Figure 6</xref>A,B, while %BChE activity are presented in 
 <xref ref-type="fig" rid="brainsci-11-00259-f007">Figure 7</xref>A,B. %AChE activity in the frontal cortex and hippocampus of scopolamine-treated groups were 51.2 + 0.2 and 44.4 + 0.4, while %BChE activities were 49.0 + 0.4 and 60.4 + 0.2 which were significantly (
 <italic>p</italic> &lt; 0.01) ** higher than that of the normal saline group. In Fa.EtAc + Scop (50mg/kg, p.o.), Fa.EtAc +Scop (100 mg/kg, p.o.), and Fa.EtAc + Scop (200 mg/kg, p.o.)-treated groups, and DZP + Scop (20 mg/kg; (i.p.) a standard drug-treated group, a significant decline (
 <italic>p</italic> &lt; 0.01) 
 <sup>##</sup>; (
 <italic>p</italic> &lt; 0.001) 
 <sup>###</sup> in %AChE and %BChE activities were observed in frontal cortex and hippocampus tissues which were lower than that of the scopolamine-treated group. 
</p>
